Jiang, T., Hu, B., Li, Y., & Yu, S. Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway. Wiley.
Chicago Style (17th ed.) CitationJiang, Tao, Bingde Hu, Yongxia Li, and Shuihong Yu. Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway. Wiley.
MLA (9th ed.) CitationJiang, Tao, et al. Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway. Wiley.
Warning: These citations may not always be 100% accurate.